Definitive Healthcare Q2 revenue down 9% to $55.2M; adjusted profit beats guidance

Definitive Healthcare Corp.

Q2 2026 revenue $55.2M, down 9% from $60.8M YoY; net loss improved to $(7.5)M from $(9.3)M.
Adjusted EBITDA $14.6M (26% margin) vs $18.7M (31% margin) in Q2 2025; adjusted net income $7.5M.
Operating cash flow $11.5M; unlevered free cash flow $11.6M; launched AI platform Turbo.
Q3 2026 guidance: revenue $54.0-55.0M, adjusted EBITDA $13.5-14.5M; FY26 revenue $220-222M, adj EPS $0.18-0.20.
Second consecutive quarter of YoY net dollar retention improvement; six-figure win-back deal.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.